Abstract | BACKGROUND: A multi-drug delivery platform is needed as the intra-tumoral heterogeneity of cancer leads to different drug susceptibility. Cancer stem cells (CSCs), a small population of tumor cells responsible for tumor seeding and recurrence, are considered chemotherapy-resistant and have been reported to be sensitive to salinomycin (Sal) instead of paclitaxel (Ptx). Here we report a novel silk fibroin (SF) hydrogel-loading Sal and Ptx by incorporating drug-loaded silk fibroin nanoparticles (SF-NPs) to simultaneously kill CSCs and non-CSCs. METHODS: Using the method we have previously reported to prepare Ptx-loaded SF-NPs (Ptx-SF-NPs), Sal-loaded SF-NPs (Sal-SF-NPs) were fabricated under mild and non-toxic conditions. The drug-loaded SF-NPs were dispersed in the ultrasound processed SF solution prior to gelation. RESULTS: The resulting SF hydrogel (Sal-Ptx-NP-Gel) retained its injectable properties, exhibited bio-degradability and demonstrated homogeneous drug distribution compared to the non-NP incorporated hydrogel. Sal-Ptx-NP-Gel showed superior inhibition of tumor growth compared to single drug-loaded hydrogel and systemic dual drug administration in the murine hepatic carcinoma H22 subcutaneous tumor model. Sal-Ptx-NP-Gel also significantly reduced CD44+CD133+ tumor cells and demonstrated the least tumor formation in the in vivo tumor seeding experiment, indicating superior inhibition of cancer stem cells. CONCLUSION: These results suggest that SF-NPs incorporated SF hydrogel is a promising drug delivery platform, and Sal-Ptx-NP-Gel could be a novel and powerful locoregional tumor treatment regimen in the future.
|
Authors | Puyuan Wu, Qin Liu, Qin Wang, Hanqing Qian, Lixia Yu, Baorui Liu, Rutian Li |
Journal | International journal of nanomedicine
(Int J Nanomedicine)
Vol. 13
Pg. 5405-5418
( 2018)
ISSN: 1178-2013 [Electronic] New Zealand |
PMID | 30271137
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Hydrogels
- Pyrans
- salinomycin
- Fibroins
- Paclitaxel
|
Topics |
- Animals
- Antineoplastic Agents
(pharmacology, therapeutic use)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Drug Delivery Systems
- Drug Liberation
- Fibroins
(chemistry)
- Humans
- Hydrogels
(chemistry)
- Male
- Mice, Inbred ICR
- Nanoparticles
(chemistry, toxicity, ultrastructure)
- Neoplastic Stem Cells
(drug effects, pathology)
- Paclitaxel
(pharmacology, therapeutic use)
- Pyrans
(pharmacology, therapeutic use)
- Toxicity Tests
|